1. Home
  2. OPK vs PGRE Comparison

OPK vs PGRE Comparison

Compare OPK & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • PGRE
  • Stock Information
  • Founded
  • OPK 2007
  • PGRE 1978
  • Country
  • OPK United States
  • PGRE United States
  • Employees
  • OPK N/A
  • PGRE N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • PGRE Real Estate Investment Trusts
  • Sector
  • OPK Health Care
  • PGRE Real Estate
  • Exchange
  • OPK Nasdaq
  • PGRE Nasdaq
  • Market Cap
  • OPK 1.0B
  • PGRE 1.4B
  • IPO Year
  • OPK 1995
  • PGRE 2014
  • Fundamental
  • Price
  • OPK $1.39
  • PGRE $6.55
  • Analyst Decision
  • OPK Buy
  • PGRE Hold
  • Analyst Count
  • OPK 4
  • PGRE 5
  • Target Price
  • OPK $2.75
  • PGRE $5.55
  • AVG Volume (30 Days)
  • OPK 2.0M
  • PGRE 5.9M
  • Earning Date
  • OPK 11-06-2025
  • PGRE 10-29-2025
  • Dividend Yield
  • OPK N/A
  • PGRE N/A
  • EPS Growth
  • OPK N/A
  • PGRE N/A
  • EPS
  • OPK N/A
  • PGRE N/A
  • Revenue
  • OPK $664,029,000.00
  • PGRE $701,980,000.00
  • Revenue This Year
  • OPK N/A
  • PGRE $1.41
  • Revenue Next Year
  • OPK $0.84
  • PGRE N/A
  • P/E Ratio
  • OPK N/A
  • PGRE N/A
  • Revenue Growth
  • OPK N/A
  • PGRE 35.23
  • 52 Week Low
  • OPK $1.11
  • PGRE $3.75
  • 52 Week High
  • OPK $2.04
  • PGRE $7.85
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • PGRE 39.40
  • Support Level
  • OPK $1.34
  • PGRE $7.00
  • Resistance Level
  • OPK $1.44
  • PGRE $7.85
  • Average True Range (ATR)
  • OPK 0.04
  • PGRE 0.23
  • MACD
  • OPK -0.00
  • PGRE -0.07
  • Stochastic Oscillator
  • OPK 50.00
  • PGRE 2.61

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About PGRE Paramount Group Inc.

Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.

Share on Social Networks: